This content is restricted; Click to Know More
Role | Deep Tech Used | Industry | Potential Vector | Potential Vector Benefit |
---|---|---|---|---|
CEO | Artificial Intelligence (AI) Biotechnology |
Healthcare & Pharmaceuticals | Growth | 45% |
Advancing antibody development with AI improves disease targeting by analyzing vast biological data to design antibodies that bind more effectively to specific disease targets. This approach accelerates drug discovery, enhances treatment precision, and holds promise for more effective therapies against various diseases.
Request for Full Version